Milestone Scientific, Inc. (MLSS) News

Milestone Scientific, Inc. (MLSS): $0.98

0.07 (+7.10%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter MLSS News Items

MLSS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest MLSS News From Around the Web

Below are the latest news stories about Milestone Scientific Inc that investors may wish to consider to help them evaluate MLSS as an investment opportunity.

Milestone Scientific to Present at MicroCap Rodeo’s Winter Wonderland Best Ideas Conference on Wednesday, February 9

ROSELAND, N.J., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that the Company has been invited to present at The MicroCap Rodeo’s 2nd Annual Winter Wonderland Best Ideas Conference, which is being held virtually on February 8 - 11, 2022. Arjan Haverhals, Chief Executive Officer of Milestone Scientific, is scheduled to present on Wednesday, Febru

Yahoo | February 7, 2022

36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022

RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8th \- 11th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.The virtual conference begins on Tuesday, February 8th, 2022, with company presentations beginning at 8:30 am Eastern Time.

Yahoo | January 28, 2022

Milestone Scientific CEO to Participate in Fireside Chat Hosted by Maxim Group and M-Vest on January 20th

ROSELAND, N.J., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide virtually painless and precise injections, today announced that Arjan Haverhals, CEO and president of Milestone Scientific, will participate in a virtual fireside chat hosted by Anthony Vendetti, executive managing director of research at Maxim Group LLC. Fireside Chat Event Info: Date: Thursday, January 20, 2022Time: 11:00 a.m. ESTW

Yahoo | January 18, 2022

Milestone Scientific expects revenue to grow 85% to $10M in FY21

Milestone Scientific (MLSS) forecasts revenue to grow 85% to over $10M in FY21 compared to revenue of $5.4M in FY20.It also expects revenue of over $2.6M in Q4 2021 compared to $2.2M in

Seeking Alpha | January 10, 2022

Milestone Scientific Projects Revenue to Increase Over 85% to More than $10 Million for 2021

ROSELAND, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide virtually painless and precise injections, today provided revenue guidance for the fourth quarter and year ended December 31, 2021. The Company anticipates revenue of over $2.6 million for the fourth quarter of 2021 compared to $2.2 million for the fourth quarter of 2020 and revenue in excess of $10 million for the fiscal year 2021 c

Yahoo | January 10, 2022

Milestone Scientific to Present at the H.C. Wainwright BioConnect 2022 Conference

ROSELAND, N.J., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer of Milestone Scientific, will be presenting at the H.C. Wainwright BioConnect 2022 Conference being held virtually January 10-13, 2022. Milestone’s presentation will be available on-demand to registered attendees via the conference platform

Yahoo | January 7, 2022

Milestone Scientific Announces Purchase of CompuFlo / CathCheck™ Verification System Disposables at Two Additional Premier Hospitals

Both hospitals belong to large hospital systems representing future growth opportunitiesROSELAND, N.J., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced the purchase of its CompuFlo® Epidural and CathCheck™ Verification System disposables from two additional leading hospitals, expanding the Company’s geographic footprint. Arjan Haverhals, CEO of Mil

Yahoo | December 28, 2021

Milestone Scientific Names Andau Medical as an Additional Distributor for the STA Single Tooth Anesthesia System® in North America

ROSELAND, N.J., Dec. 23, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced it has entered into an agreement with Andau Medical to distribute the STA Single Tooth Anesthesia System ® in the United States and Canada.

GlobeNewswire | December 23, 2021

Milestone Scientific in pact with a Northeast hospital for health instruments

No summary available.

Seeking Alpha | December 22, 2021

Milestone Scientific Inc. (NYSEAMERICAN:MLSS) Director Sells $10,100.00 in Stock

Milestone Scientific Inc. (NYSEAMERICAN:MLSS) Director Leonard Osser sold 5,000 shares of the firms stock in a transaction that occurred on Monday, December 20th. The shares were sold at an average price of $2.02, for a total value of $10,100.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is []

Transcript Daily | December 22, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5129 seconds.